Cargando…
Low-coverage whole-genome sequencing of cerebrospinal-fluid-derived cell-free DNA in brain tumor patients
This protocol summarizes the pipeline for analysis of tumor-derived cell-free DNA (cfDNA) from cerebrospinal fluid (CSF) using low-coverage whole-genome sequencing (lcWGS). This approach enables resolution of chromosomal and focal copy-number variations (CNVs) as oncologic signatures, particularly f...
Autores principales: | Liu, Anthony P.Y., Smith, Kyle S., Kumar, Rahul, Robinson, Giles W., Northcott, Paul A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026582/ https://www.ncbi.nlm.nih.gov/pubmed/35463474 http://dx.doi.org/10.1016/j.xpro.2022.101292 |
Ejemplares similares
-
Whole-genome sequencing of extrachromosomal circular DNA of cerebrospinal fluid of medulloblastoma
por: Zhu, Yi, et al.
Publicado: (2022) -
Reliable tumor detection by whole-genome methylation sequencing of cell-free DNA in cerebrospinal fluid of pediatric medulloblastoma
por: Li, Jia, et al.
Publicado: (2020) -
A protocol for collection and infusion of cerebrospinal fluid in mice
por: Kaur, Achint, et al.
Publicado: (2023) -
A protocol for applying low-coverage whole-genome sequencing data in structural variation studies
por: Liu, Qi, et al.
Publicado: (2023) -
Low-pass whole-genome and targeted sequencing of cell-free DNA from cerebrospinal fluid in pediatric patients with central nervous system tumors
por: O’Halloran, Katrina, et al.
Publicado: (2023)